A relative bioavailability study of 500 mg calcium p-aminosalicylate film coating tablet in healthy individuals

The purpose of this study is to evaluate the only available calcium p-aminosalicylate (Ca PAS) commercial product, which is one of the most commonly prescribed non-surveillance products from the Bureau of National Health Insurance (BNHI) database in Taiwan. An open-randomized, balanced, two-way cros...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Chinhwa, Chen, Mei-Ling, Tseng, Chiachi, Uang, Yow-Shieng, Huang, Chyn-Liang, Hsu, Kuang-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359332/
http://dx.doi.org/10.1016/j.jfda.2013.09.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359332/
http://dx.doi.org/10.1016/j.jfda.2013.09.014

Ejemplares similares